Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to linoleic acid (LA) in combination with gamma-linolenic acid (GLA) and reduction of ocular dryness. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food that is the subject of the health claims is linoleic acid in combination with gamma-linolenic acid. The Panel considers that the food constituents, linoleic acid and gamma-linolenic acid, are sufficiently characterised. The claimed effect is “ocular comfort”. The target population is assumed to be the general population. In the context of the proposed wordings, the Panel assumes that the claimed effect refers to the reduction of ocular dryness by promoting tear production. The Panel considers that reduction of ocular dryness is a beneficial physiological effect. No references were provided from which conclusions could be drawn for the scientific substantiation of the claim. On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the consumption of linoleic acid in combination with gamma-linolenic acid and reduction of ocular dryness.
EFSA Publication (2011). EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to linoleic acid (LA) in combination with gamma-linolenic acid (GLA) and reduction of ocular dryness (ID 4274) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. European Food Safety Authority. the EFSA Journal, No. 2230 https://doi.org/10.2903/j.efsa.2011.2230